Rezolute Announces Pricing of Approximately $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Transaction led by Frazier Life Sciences with participation from new and existing funds
Covered in this story
Call it yourself
No calls on $RZLT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Rezolute Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.